REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/04/2026
Back to search
Official data from USPTO
AMP: ACCESS FOR MORE PATIENTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AMP: ACCESS FOR MORE PATIENTS
ST13
US500000088730537Class
42
Filing
88730537
Registration
6337864
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
05/05/2026
Trademark type
Word
Nice classes
42
Filing date
12/17/2019
Registration date
05/04/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/04/2021
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/18/2019
First use in commerce
10/01/2019
Drawing code
4
Owner type
03
Owner location
Irving, TX, US
Examiner
THOMAS-RIGGS, LESLIE A
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
M. C. (pessoa física)
Representatives
Auma N. Reggy MCKESSON CORPORATION
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Software as a service (SAAS) services marketed and sold exclusively to pharmaceutical manufacturers and insurance companies featuring software for facilitating the prescription ofaccess to covered specialty medications and medical treatments by enabling intra provider-insurer-pharmacy communications for purposes of investigating and verifying patient-specific benefits coveragefor processing prior medical authorizationsfor locating and facilitating patient access to financial assistancefor scheduling laboratory tests and first dose observationsfor transmitting prescriptions to a patient's preferred pharmacyfor supporting pharmaceutical companies in risk evaluation and mitigation strategy programs; and specifically excluding software permitting health care providers and patients to communicate via a customized private website to collectanalyzemanagesharereport or compare patient datarehabilitation tracking and patient progress
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/04/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/16/2021
PUBO
PUBLISHED FOR OPPOSITION
02/16/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/27/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
01/08/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/08/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
01/08/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/11/2020
GNRT
NON-FINAL ACTION E-MAILED
06/11/2020
CNRT
NON-FINAL ACTION WRITTEN
06/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/20/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/20/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/16/2020
GNRT
NON-FINAL ACTION E-MAILED
01/16/2020
CNRT
NON-FINAL ACTION WRITTEN
01/16/2020
DOCK
ASSIGNED TO EXAMINER
01/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/20/2019
NWAP
NEW APPLICATION ENTERED
12/20/2019
Continuous trademark protection
Get notified about every new filing that threatens AMP: ACCESS FOR MORE PATIENTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.